ORI Introduction to RCR: Chapter 2. Research Misconduct
Policies, Reports, and Policy Statements
Wells, FO, Lock, S, Farthing, MJG. Fraud and Misconduct in Biomedical Research, London: BMJ Books, 2001.
Department of Health and Human Services. Commission on Research Integrity. Integrity and Misconduct in Research, Washington, DC: Health and Human Services, 1995.
National Academy of Science. Committee on Science Engineering and Public Policy. Panel on Scientific Responsibility and the Conduct of Research. Responsible Science: Ensuring the Integrity of the Research Process, Washington, DC: National Academy Press, 1992.
National Science Foundation. Research Misconduct, 45 CFR 689 (1987). (Link
Office of the President. Office of Science and Technology Policy. “Federal Policy on Research Misconduct,” Federal Register 65 (6 December 2000): 76260-64.
Office of Research Integrity, ORI Model Policy and Procedures for Responding to Allegations of Scientific Misconduct, 1995, revised 1997. (Link
Public Health Service. Responsibility of PHS Awardee and Applicant Institutions for Dealing With and Reporting Possible Misconduct in Science, 42 CFR Part 50, Subpart A (1989). (Link
United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight. Fraud in Biomedical Research, Washington, DC: GPO, 1981.
General Information Web Sites
National Science Foundation, Office of Inspector General. Home Page, 2003. (Link
Office of Research Integrity. Handling Misconduct, 2003. (Link
Braxton, JM, Bayer, AE. “Perceptions of Research Misconduct and an Analysis of their Correlates.” In Perspectives on Scholarly Misconduct in the Sciences, edited by John M. Braxton, Columbus, OH: Ohio State University Press, 1999, 236-258.
Korenman, SG, Berk, R, Wenger, NS, Lew, V. “Evaluation of the Research Norms of Scientists and Administrators Responsible for Academic Research Integrity,” Journal of the American Medical Association 279, 1 (1998): 41-47.
Parrish, DM. “Scientific Misconduct and Correcting the Scientific Literature,” Academic Medicine 74, 3 (1999): 221-230.
Pascal, CB. “Scientific Misconduct and Research Integrity for the Bench Scientist,” Proceedings of the Society for Experimental Biology and Medicine 224, 4 (2000): 220-230.
Price, AR. “Anonymity and Pseudonymity in Whistleblowing to the U.S. Office of Research Integrity,” Academic Medicine 73, 5 (1998): 467-472.
Rhoades, LR. “The American Experience: Lessons Learned,” Science and Engineering Ethics 6,1 (2000): 95-107.
School of Education. University of Indiana. Understanding Plagiarism, 2002. (Link
United States. President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Whistleblowing in Biomedical Research: Policies and Procedures for Responding to Reports of Misconduct: Proceedings of a Workshop, September 21-22, 1981, Washington, DC: GPO, 1981.